Statera Biopharma Ownership 2024 | Who Owns Statera Biopharma Now?


OverviewChart

Institutional Ownership

0.00%

0

Institutional Holders

1.00

Statera Biopharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC100.00%-211,836-223,026-51.29%3,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC0.70%-1,000--18,000Mar 31, 2023
IFP ADVISORS, INC0.06%-87-500-85.18%271,000Mar 31, 2023
HRT FINANCIAL LP----24,494-100.00%-Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC----17,000-100.00%-Mar 31, 2023
MORGAN STANLEY----60-100.00%-Mar 31, 2023
UBS GROUP AG----2,011-100.00%-Mar 31, 2023
ERGOTELES LLC----28,325-100.00%-Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.----30,000-100.00%-Mar 31, 2023
BANK OF AMERICA CORP /DE/----100-100.00%-Mar 31, 2023
TWO SIGMA SECURITIES, LLC----81,303-100.00%-Mar 31, 2023
WELLS FARGO & COMPANY/MN----287-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----171,110-100.00%-Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/----61,200-100.00%-Mar 31, 2023
STATE STREET CORP----68,247-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----722,390-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----29,967-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----130,774-100.00%-Mar 31, 2023
VANGUARD GROUP INC----378,677-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----58,579-100.00%-Mar 31, 2023

Statera Biopharma's largest institutional shareholder is ACADIAN ASSET MANAGEMENT LLC, holding 100.00% of the company's total share outstanding, currently valued at $3.00K. The top 10 institutional shareholders own together 100.76% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC100.00%-211,836-223,026-51.29%3,000Mar 31, 2023
IFP ADVISORS, INC0.06%-87-500-85.18%271,000Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC0.70%-1,000--18,000Mar 31, 2023
HRT FINANCIAL LP----24,494-100.00%-Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC----17,000-100.00%-Mar 31, 2023
MORGAN STANLEY----60-100.00%-Mar 31, 2023
UBS GROUP AG----2,011-100.00%-Mar 31, 2023
ERGOTELES LLC----28,325-100.00%-Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.----30,000-100.00%-Mar 31, 2023
BANK OF AMERICA CORP /DE/----100-100.00%-Mar 31, 2023
TWO SIGMA SECURITIES, LLC----81,303-100.00%-Mar 31, 2023
WELLS FARGO & COMPANY/MN----287-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----171,110-100.00%-Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/----61,200-100.00%-Mar 31, 2023
STATE STREET CORP----68,247-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----722,390-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----29,967-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----130,774-100.00%-Mar 31, 2023
VANGUARD GROUP INC----378,677-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----58,579-100.00%-Mar 31, 2023

The largest Statera Biopharma shareholder by % of total assets is ACADIAN ASSET MANAGEMENT LLC. The company owns 211.84K shares of Statera Biopharma (STAB), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TUCKER ASSET MANAGEMENT LLC0.70%-1,000--18,000Mar 31, 2023
MORGAN STANLEY----60-100.00%-Mar 31, 2023
BANK OF AMERICA CORP /DE/----100-100.00%-Mar 31, 2023
WELLS FARGO & COMPANY/MN----287-100.00%-Mar 31, 2023
ARCHER INVESTMENT CORP----300-100.00%-Mar 31, 2023
IFP ADVISORS, INC0.06%-87-500-85.18%271,000Mar 31, 2023
NATIONAL BANK OF CANADA /FI/----1,000-100.00%-Mar 31, 2023
UBS GROUP AG----2,011-100.00%-Mar 31, 2023
UNITED CAPITAL MANAGEMENT OF KS, INC.----15,000-100.00%-Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC----17,000-100.00%-Mar 31, 2023
HRT FINANCIAL LP----24,494-100.00%-Mar 31, 2023
ERGOTELES LLC----28,325-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----29,967-100.00%-Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.----30,000-100.00%-Mar 31, 2023
CI PRIVATE WEALTH, LLC----43,350-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----58,579-100.00%-Mar 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----59,825-100.00%-Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/----61,200-100.00%-Mar 31, 2023
STATE STREET CORP----68,247-100.00%-Mar 31, 2023
TWO SIGMA SECURITIES, LLC----81,303-100.00%-Mar 31, 2023

As of Mar 31 2023, Statera Biopharma's largest institutional buyer is TUCKER ASSET MANAGEMENT LLC. The company purchased 0.00 stocks of STAB, valued at $18.00K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC----722,390-100.00%-Mar 31, 2023
VANGUARD GROUP INC----378,677-100.00%-Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC100.00%-211,836-223,026-51.29%3,000Mar 31, 2023
NORTHERN TRUST CORP----171,110-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----130,774-100.00%-Mar 31, 2023
BLACKROCK INC.----109,531-100.00%-Mar 31, 2023
TWO SIGMA SECURITIES, LLC----81,303-100.00%-Mar 31, 2023
STATE STREET CORP----68,247-100.00%-Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/----61,200-100.00%-Mar 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----59,825-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----58,579-100.00%-Mar 31, 2023
CI PRIVATE WEALTH, LLC----43,350-100.00%-Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.----30,000-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----29,967-100.00%-Mar 31, 2023
ERGOTELES LLC----28,325-100.00%-Mar 31, 2023
HRT FINANCIAL LP----24,494-100.00%-Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC----17,000-100.00%-Mar 31, 2023
UNITED CAPITAL MANAGEMENT OF KS, INC.----15,000-100.00%-Mar 31, 2023
UBS GROUP AG----2,011-100.00%-Mar 31, 2023
NATIONAL BANK OF CANADA /FI/----1,000-100.00%-Mar 31, 2023

As of Mar 31 2023, Statera Biopharma's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -0.72M shares of STAB, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC----722,390-100.00%-Mar 31, 2023
VANGUARD GROUP INC----378,677-100.00%-Mar 31, 2023
NORTHERN TRUST CORP----171,110-100.00%-Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----130,774-100.00%-Mar 31, 2023
BLACKROCK INC.----109,531-100.00%-Mar 31, 2023
TWO SIGMA SECURITIES, LLC----81,303-100.00%-Mar 31, 2023
STATE STREET CORP----68,247-100.00%-Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/----61,200-100.00%-Mar 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----59,825-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----58,579-100.00%-Mar 31, 2023
CI PRIVATE WEALTH, LLC----43,350-100.00%-Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.----30,000-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----29,967-100.00%-Mar 31, 2023
ERGOTELES LLC----28,325-100.00%-Mar 31, 2023
HRT FINANCIAL LP----24,494-100.00%-Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC----17,000-100.00%-Mar 31, 2023
UNITED CAPITAL MANAGEMENT OF KS, INC.----15,000-100.00%-Mar 31, 2023
UBS GROUP AG----2,011-100.00%-Mar 31, 2023
NATIONAL BANK OF CANADA /FI/----1,000-100.00%-Mar 31, 2023
ARCHER INVESTMENT CORP----300-100.00%-Mar 31, 2023
WELLS FARGO & COMPANY/MN----287-100.00%-Mar 31, 2023
BANK OF AMERICA CORP /DE/----100-100.00%-Mar 31, 2023
MORGAN STANLEY----60-100.00%-Mar 31, 2023

Statera Biopharma's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -0.72M shares, valued at -, as of undefined.

Statera Biopharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%28,249--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%378,677--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%114,324--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%12,170--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%61,200--Jan 31, 2024
iSHARES TRUST0.00%108,153--Feb 29, 2024
EQ ADVISORS TRUST0.00%4,523--Dec 31, 2023

Statera Biopharma's largest mutual fund holder by % of total assets is "VANGUARD INSTITUTIONAL INDEX FUNDS", owning 28.25K shares, compromising 0.00% of its total assets.

Statera Biopharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 231-
30 Jun, 231-66.67%
31 Mar, 233-88.46%
31 Dec, 22264.00%
30 Sep, 2225-3.85%
30 Jun, 2226-
31 Mar, 2226-
31 Dec, 212636.84%
30 Sep, 2119-

As of 31 Dec 23, 1 institutions are holding Statera Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 231,000-
30 Jun, 231,000-99.53%
31 Mar, 23212,923-91.38%
31 Dec, 222,470,279-16.21%
30 Sep, 222,948,266-1.77%
30 Jun, 223,001,44440.83%
31 Mar, 222,131,2304.92%
31 Dec, 212,031,19868.47%
30 Sep, 211,205,693-

Statera Biopharma (STAB) has 1.00K shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 230.00%-
30 Jun, 230.00%1.11%
31 Mar, 230.42%1.75%
31 Dec, 224.92%14.28%
30 Sep, 225.87%16.07%
30 Jun, 226.04%19.47%
31 Mar, 225.57%16.65%
31 Dec, 215.79%29.09%
30 Sep, 214.46%-

As of 31 Dec 23, Statera Biopharma is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 231-
30 Jun, 23--
31 Mar, 23--100.00%
31 Dec, 221183.33%
30 Sep, 226-33.33%
30 Jun, 229-47.06%
31 Mar, 2217-15.00%
31 Dec, 21205.26%
30 Sep, 2119-

1 institutional shareholders have increased their position in STAB stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23--
30 Jun, 23--100.00%
31 Mar, 232-71.43%
31 Dec, 22716.67%
30 Sep, 226-
30 Jun, 22620.00%
31 Mar, 225150.00%
31 Dec, 212-
30 Sep, 21--

- institutional shareholders have reduced their position in STAB stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 231-1,000-0.00%-1---
30 Jun, 231-66.67%1,000-99.53%0.00%1.11%----100.00%
31 Mar, 233-88.46%212,923-91.38%0.42%1.75%--100.00%2-71.43%
31 Dec, 22264.00%2,470,279-16.21%4.92%14.28%1183.33%716.67%
30 Sep, 2225-3.85%2,948,266-1.77%5.87%16.07%6-33.33%6-
30 Jun, 2226-3,001,44440.83%6.04%19.47%9-47.06%620.00%
31 Mar, 2226-2,131,2304.92%5.57%16.65%17-15.00%5150.00%
31 Dec, 212636.84%2,031,19868.47%5.79%29.09%205.26%2-
30 Sep, 2119-1,205,693-4.46%-19---

Statera Biopharma Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 23, 2021Miller Langdon Lofficer Chief Medical OfficerM-ExemptSell10,000$3.00$30.00K-
Dec 23, 2019Zosh Christopherofficer Vice President of FinanceSell300$3.20$960.00-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 21, 2022Chandrasekhar Satishchandrandirector Buy----
Oct 28, 2021SALUCK RANDY S.director-A-AwardBuy60,000--60,140
Oct 19, 2021Barbarick Steve Kdirector-A-AwardBuy60,000--60,000
Oct 19, 2021Verny Leadirector-A-AwardBuy60,000--60,000
Sep 30, 2021Markvicka Tauniadirector, officer Chief Operating OfficerA-AwardBuy100,000--100,000
Aug 04, 2021Handley Michael Kdirector, officer President and CEOA-AwardBuy296,609--296,609
Aug 04, 2021Handley Michael Kdirector, officer President and CEOBuy----
Jul 29, 2021Buckheit Robertofficer Chief Technology OfficerA-AwardBuy24,378--24,378
Jul 29, 2021Selsky Cliffordofficer Chief Medical OfficerA-AwardBuy101,579--101,579
Jul 29, 2021McAvoy Cozette M.officer Chief Legal OfficerA-AwardBuy60,947--60,947
Jul 29, 2021ARONSTAM PETERofficer Chief Financial OfficerA-AwardBuy141,370--141,370
Jul 29, 2021Buckheit Robertofficer-Buy----
Jul 29, 2021Selsky Cliffordofficer-Buy----
Jul 29, 2021ARONSTAM PETERofficer-Buy----
Jul 29, 2021Barbarick Steve Kdirector Buy----
Jul 29, 2021McAvoy Cozette M.officer-Buy----
Jul 29, 2021Markvicka Tauniadirector, officer Chief Operating OfficerBuy----
Jul 23, 2021Miller Langdon Lofficer Chief Medical OfficerM-ExemptBuy10,000$3.00$30.00K10,000
Jul 23, 2021Miller Langdon Lofficer Chief Medical OfficerM-ExemptSell10,000$3.00$30.00K-
Dec 23, 2019Zosh Christopherofficer Vice President of FinanceSell300$3.20$960.00-

The last insider sell of Statera Biopharma's stock was made by Miller Langdon L on Jul 23 2021, selling 10,000 shares at $3.00 per share (valued at $30.00K).

Statera Biopharma Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2022---
Q3 20211011000.00%
Q3 2018---
Q2 2017-6-
Q3 2016-4-
Q2 2016---
Q3 2015-2-
Q2 201510--
Q1 20154--
Q4 2014---
Q3 201411100.00%
Q2 2014102500.00%
Q1 20145--
Q2 20132121050.00%
Q1 20131--
Q4 201221200.00%
Q3 20122--
Q2 201214--
Q1 201283266.67%
Q4 20119--

0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Statera Biopharma's insiders, as of Q1 2022.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2022---
Q3 2021---
Q3 2018---
Q2 2017---
Q3 2016---
Q2 2016---
Q3 2015---
Q2 2015---
Q1 20151--
Q4 2014---
Q3 2014---
Q2 2014---
Q1 2014---
Q2 20132--
Q1 20131--
Q4 2012---
Q3 20122--
Q2 20122--
Q1 201243133.33%
Q4 20115--

As of Q1 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Statera Biopharma's stocks.

Statera Biopharma Peer Ownership


TickerCompany
KROSKeros Therapeutics, Inc.
ELYMEliem Therapeutics, Inc.
AADIAadi Bioscience, Inc.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
ALECAlector, Inc.

STAB Ownership FAQ


Statera Biopharma is owned by institutional shareholders (0.00%), insiders (0.00%), and public (100.00%). The largest institutional shareholder of Statera Biopharma is ACADIAN ASSET MANAGEMENT LLC (100.00% of total shares) and the top mutual fund owner is VANGUARD INSTITUTIONAL INDEX FUNDS (0.00% of total shares).

Statera Biopharma's major institutional shareholders are ACADIAN ASSET MANAGEMENT LLC, TUCKER ASSET MANAGEMENT LLC, IFP ADVISORS, INC, HRT FINANCIAL LP, and BELL & BROWN WEALTH ADVISORS, LLC. The top five shareholders own together 100.76% of the company's share outstanding.

As of Dec 2023, there are 1 institutional shareholders of Statera Biopharma.

ACADIAN ASSET MANAGEMENT LLC owns 211.84K shares of Statera Biopharma, representing 100.00% of the company's total shares outstanding, valued at $3K (as of Mar 2023).

As of Mar 2023, TUCKER ASSET MANAGEMENT LLC holds 1K shares of Statera Biopharma (STAB), compromising 0.70% of the company, valued at $18K.

IFP ADVISORS, INC is the third largest holder of Statera Biopharma. The company owns 87 of the company's shares outstanding (worth $271K).